(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDIX BIOCHEMICA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MEDIX BIOCHEMICA

ST13

US500000079358529

Class

1, 5, 10, 40, 42, 44

Filing

79358529

Registration

7636487

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

04/03/2026

Trademark type

Combined

Nice classes

1, 5, 10, 40, 42, 44

Filing date

05/19/2022

Registration date

01/07/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/07/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

FI

Examiner

BODRI, KRISTIN MARIE

Law office

L50

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the wording "MEDIX" in blue and "BIOCHEMICA" with "BI" and "CHEMICA" in blue and "O" in red, all on a transparent background.

Holders and representatives

Holders

Oy Medix Biochemica Ab

Representatives

ROGER H. BORA THOMPSON HINE LLP

Technical classification

Nice Classes

Class 1Class 5Class 10Class 40Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Reagents for use in scientific and medical research; diagnostic preparations for medical research; reagent media for medical research; chemical test paper; protein arrays and nucleotide arrays for scientific and medical research; diagnostic preparations for scientific or research use; antibodies for use in scientific and medical research in the nature of mononuclean antibodies; assays for research purposes; buffer solutions for use in analytical chemistry; control reagents for research purposes for use with scientific apparatus and instruments; protein labelling kits comprising reagents for use in scientific and medical research; assay kits consisting of chemical reagents for scientific and medical research; assay kits consisting of biological reagents for scientific and medical research; protein in raw material form for scientific and medical research; proteins in raw material form for scientific and medical research for detecting antibodies; diagnostic reagents for scientific or research use; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; chemicals for use in biotechnological manufacturing processes and product development; nucleotides for scientific and research use; proteins for use in manufacture; reagent medium for medical research

Class 5

Chemical reagents for medical or veterinary purposes; medical diagnostic reagents; veterinary diagnostic reagents; reagents for medical use; chemical and biological antigens for medical diagnostic use; clinical medical reagents; pharmaceutical preparations for diagnostic purposes; monoclonal antibodies for medical and diagnostic use; pregnancy and fertility test kits for home and medical use; medical diagnostic test strips for home and medical use for use in the fields of immunologydermatologyneurologyobstetricsgynecologyreproductive biologybroncologypulmonologyrespiratologyophthalmologyorthopedic surgeryotologylaryngologypathologypediatrics and oncology; diagnostic preparations for medical use; reagent media for medical diagnostic purposes; medical immunological diagnostic reagents; diagnostic agents for pharmaceutical use; diagnostic biomarker reagents for medical purposes; protein arrays for diagnosing cancer; monoclonal antibodies for use in disease testing; leukocyte antibodies for use in disease testing; cytokines and chemokines for use in disease testing; adhesion molecules for use in disease testing; endothelial cells for medical use; progenitor cells for medical use; medical diagnostic reagents and assays for detecting apoptosis; medical diagnostic reagents for cellular transduction; stem cells for medical use

Class 10

Medical testing devices utilizing immunological methodsin the form of kits primarily comprised of test strips capable of visual or instrument read out of test resultsbuffer tubesmedical specimen collection loops and vialsfor use in testing of bloodplasmaserumother bodily fluidsalso including cotton swabs and pads for medical purposes; medical diagnostic instruments for in vitro diagnostic testing and in vitro analysis utilizing immunological methods for use in the field of immunologyanesthesiadermatologyneurologyobstetricsgynecologyreproductive biologybroncologypulmonologyrespiratologyophthalmologyorthopedic surgeryotologylaryngologypathologypediatricsradiologyradiationoncologysurgery; medical apparatus and instrumentsdiagnostic testing apparatus and instruments for medical use for use in in vitro diagnostic testing procedurescardiovascular diagnosis and screeningdiabetes monitoring and diagnosispregnancy monitoringmonitoring and diagnosing metabolic functionsdetectingscreening and monitoring infectious diseasesinflammatory diseasesskin disordersthyroid diseases and cancer; medical apparatus and instrumentsdiagnostic testing apparatus and instruments for blood analysisurine analysisfecal analysissaliva analysisanalysis of oral fluidsanalysis of amniotic fluidsanalysis of cervicospinal fluidanalysis of ascitesanalysis of pleural fluidsanalysis of exudateanalysis of cervicalvaginal and cervico-vaginal secretions; in-vitro diagnostic apparatusin the form of test kits for medical purposes for professional or home use comprised of collection pads or swabscollection loops or vialstest strips capable of visual or instrument read out of test results and/or vials of developer solution or reagents; in-vitro diagnostic apparatusin the form of test kits for medical purposes for professional or home use for analysing oral fluidurinefecesamniotic fluidvaginal secretionscervical secretionscervico-vaginal secretionsfinger stick or venipuncture whole bloodplasmaserumexudateskincervicospinal fluidascitespleural fluidsother bodily fluids and specimens; in-vitro diagnostic apparatusin the form of test kits for medical purposes for professional or home use for use in detecting antibodiesantigenvirusesbacteria and other pathogensdisease markers and metabolitesfecal occult bloodhormonesvitaminsproteinsnucleic acidstoxinsdrugs and their metabolitesdrugs of abuse and chemicals

Class 40

Manufacturing of diagnostic preparations and reagent medium to order for medical use and medical research and non-medical purposes; manufacturing services for others in the field of pharmaceuticalsbiopharmaceuticalsdiagnosticshealth care products and medical products; treatment of materialspharmaceuticaldiagnostic and chemical products and their components used in the manufacture of pharmaceuticalsbiopharmaceuticalsdiagnostic preparationsreagent mediatest kitstesting apparatus and instruments; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticalsdiagnostic preparations and reagent medium

Class 42

Medical and scientific research; pharmaceutical research and development; development of antibodies for others; antibody research and development services; development of assays for diagnostic purposes; medical laboratories; conducting clinical trials; scientific research consulting services in the field of medical and health care technology; medical and pharmacological research; providing of information and data relating to medical research and development; product development for others relating to pharmaceuticalsbiopharmaceuticalshealth care products and medical products; scientific and technological consulting services in the pharmaceutical industryresearch and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticalsbiopharmaceuticalshealth care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research servicesproviding analytical testingbiosafety testingreporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays; monoclonal antibody research and development services

Class 44

Providing medical informationconsultation and advisory services; medical consulting services in the field of diagnostics; medical consulting regarding medical diagnostic apparatus and instruments; medical consulting regarding diagnostic preparations; providing medical information through a website; medical diagnostic testing and reporting services; tissue typing services in the nature of blood testing

Publications

History of USPTO decisions and trademark events.

37 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/19/2026

IRFI

IRREGULARITY ON FINAL DECISION RECEIVED FROM IB

07/12/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/02/2025

FIMP

FINAL DISPOSITION PROCESSED

07/02/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/07/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/07/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/07/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/19/2024

PUBO

PUBLISHED FOR OPPOSITION

11/19/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/13/2024

EXPT

EXPARTE APPEAL TERMINATED

10/10/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/10/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/30/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/07/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

06/07/2024

EXPI

EX PARTE APPEAL-INSTITUTED

03/28/2024

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

03/28/2024

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

03/28/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/15/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/15/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/15/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/29/2023

GNFR

FINAL REFUSAL E-MAILED

09/29/2023

CNFR

FINAL REFUSAL WRITTEN

09/29/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/08/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/08/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/08/2023

CNRT

NON-FINAL ACTION MAILED

03/14/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/14/2023

CNRT

NON-FINAL ACTION WRITTEN

03/13/2023

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

03/13/2023

PBSR

WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST

03/13/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/13/2023

DOCK

ASSIGNED TO EXAMINER

03/09/2023

MAFR

APPLICATION FILING RECEIPT MAILED

12/31/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/27/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/23/2022

Continuous trademark protection

Get notified about every new filing that threatens MEDIX BIOCHEMICA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.